Characterizing the Neural Bases of Motivational Disorders After Stroke

NCT ID: NCT03741140

Last Updated: 2025-02-20

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 66 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2020-10-22
• Study Completion Date: 2022-06-30

Brief Summary

The aim of the study is to quantify elementary mechanisms of motivation, with innovative tools adapted to clinical settings, in healthy subjects, and in stroke patients. The secondary aim of the study is to investigate the neural substrates of motivational mechanisms, and to study the impact of lesions in the grey and the white matter, the influence of lesion site.

Detailed Description

Disorders of motivation, such as apathy, are among the most prevalent symptoms in neuropsychiatric disorders and during chronic diseases. They have a major impact on patients' physical activity and lifestyle, and on their involvement in their own care. They affect a wide range of morbidity outcomes, alter functional recovery in rehabilitation, impair long-term disability, and prevent patients from returning to an active and independent life. Yet, the neural bases of motivational deficits remain largely unknown. Current diagnostic tools are sparse and cannot distinguish between distinct mechanisms responsible for apathetic syndromes. Besides, current treatments remain extremely limited. However, recent advances in the field of neuroeconomics - the science of decision-making - have provided concept and tools to study the neurobiological bases of elementary cognitive processes underlying motivated behaviors. These theories suggest that the brain implements optimization processes that determine our behaviors by minimizing the cost of our actions while maximizing their expected benefits. The adaptation of tools developed for basic research now enables the assessment of these cognitive mechanisms.

Elementary deficits of motivation will be assessed with a phenotyping battery of motivation tests in 20 healthy subjects (up to 10 healthy subjects can be replaced), 20 patients (up to 10 patients can be replaced) with a stroke in the medial prefrontal cortex, and 20 patients (up to 10 patients can be replaced) with a stroke in the insula. This battery will allow us to characterize, at the patient's level, elementary processes such as the encoding of goal values or effort costs, the modulation of cost with fatigue, and the resolution of cost-benefit trade-offs. Symptom-Lesion mapping studies and voxel-based morphometry studies will be performed using whole brain MRI measures of structural integrity.

Conditions

Stroke

Study Design

• Allocation Method: NON_RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: BASIC_SCIENCE
• Blinding Strategy: NONE

Study Groups

medial frontal stroke

20 patients (up to 10 patients can be replaced) with a stroke in the medial frontal lobe will be included in this arm, and will undergo motivation phenotyping.

Group Type: OTHER

Motivation tests

Intervention Type: DIAGNOSTIC_TEST

Motivation tests will characterize elementary deficits of motivation

lateral frontal stroke

20 patients (up to 10 patients can be replaced) with a stroke in the lateral frontal lobe will be included in this arm, and will undergo motivation phenotyping.

Group Type: OTHER

Motivation tests

Intervention Type: DIAGNOSTIC_TEST

Motivation tests will characterize elementary deficits of motivation

Healthy participants

20 healthy participants (up to 10 healthy participants can be replaced) will be included in this arm, and will undergo motivation phenotyping.

Group Type: OTHER

Motivation tests

Intervention Type: DIAGNOSTIC_TEST

Motivation tests will characterize elementary deficits of motivation

Interventions

Motivation tests

Motivation tests will characterize elementary deficits of motivation

Intervention Type: DIAGNOSTIC_TEST

Eligibility Criteria

Inclusion Criteria

• Right-handed
• Age > 18 years old
• Able to squeeze a hand-grip
• Signature of consent form
• Affiliation to an Health Insurance Scheme or beneficiary of such a scheme

• Age > 18 years old
• Able to squeeze a hand-grip
• Signature of consent form
• Affiliation to an Health Insurance Scheme or beneficiary of such a scheme
• Stroke of the medial frontal lobe and not affecting the lateral frontal lobe OR stroke of the lateral frontal lobe and not affecting the medial frontal lobe

Exclusion Criteria

• Under justice protection
• History of neurological or psychiatric diseases
• Evolving disease that could impede volunteer participation during the whole study
• Ongoing psychotropic drug or stopped for less than 3 weeks
• Treatment that could interfere with subject performance
• Chronical use of illicit psychoactive drugs or the day of the exam
• Pregnant, parturient or breastfeeding woman
• Exclusion period of another research
• Contra-indication to MRI scan
• Comprehension difficulties or difficulties to perform the study cognitive tests

• Under justice protection
• Evolving disease that could impede volunteer participation during the whole study
• Chronical use of illicit psychoactive drugs or the day of the exam
• Pregnant, parturient or breastfeeding woman
• Exclusion period of another research
• Contra-indication to MRI scan
• Comprehension difficulties or difficulties to perform the study cognitive tests
• Brain sequela with important cognitive deficiencies preventing cognitive test interpretation according to the investigator

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Urgences cérébro-vasculaires hopital Pitié-Salpêtrière

Paris, , France

Countries

France

Other Identifiers

2018-A00511-54 / 1

Identifier Type: REGISTRY

Identifier Source: secondary_id

C17-19

Identifier Type: -

Identifier Source: org_study_id